{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:08Z","timestamp":1792784828743,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003448","name":"Greek General Secretariat of Research and Technology","doi-asserted-by":"crossref","award":["4220"],"award-info":[{"award-number":["4220"]}],"id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Netherlands Organization for Scientific Research","award":["91813603"],"award-info":[{"award-number":["91813603"]}],"id":[{"id":"https:\/\/ror.org\/04jsz6e67","id-type":"ROR","asserted-by":"crossref"}]},{"name":"NIH","award":["48739"],"award-info":[{"award-number":["48739"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.atherosclerosis.2015.08.028","type":"journal-article","created":{"date-parts":[[2015,8,24]],"date-time":"2015-08-24T20:11:42Z","timestamp":1440447102000},"page":"77-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Natural human apoA-I mutations L141R Pisa and L159R FIN alter HDL structure and functionality and promote atherosclerosis development in mice"],"prefix":"10.1016","volume":"243","author":[{"given":"Ioanna","family":"Tiniakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Kanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Georgopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Chroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Van Eck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-8070","authenticated-orcid":false,"given":"Panagiotis","family":"Fotakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis I.","family":"Zannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Kardassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJM198911093211907","article-title":"High-density lipoprotein\u2013the clinical implications of recent studies","volume":"321","author":"Gordon","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.clinbiochem.2014.09.001","article-title":"Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients","volume":"47","author":"Bounafaa","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cca.2013.12.001","article-title":"HDL-cholesterol in coronary artery disease risk: function or structure?","volume":"429","author":"Perez-Mendez","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib5","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.2174\/13816128113199990298","article-title":"Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality","volume":"19","author":"Pirillo","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib6","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1194\/jlr.R037762","article-title":"High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease","volume":"54","author":"Riwanto","year":"2013","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-319-09665-0_5","article-title":"Functionality of HDL: antioxidation and Detoxifying effects","volume":"224","author":"Karlsson","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00109-005-0030-4","article-title":"Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL","volume":"84","author":"Zannis","year":"2006","journal-title":"J.\u00a0Mol. Med. (Berl)"},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1172\/JCI14011","article-title":"Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems","volume":"108","author":"Krieger","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/01.ATV.17.1.83","article-title":"Apolipoprotein A-IFin. Dominantly inherited hypoalphalipoproteinemia due to a single base substitution in the apolipoprotein A-I gene","volume":"17","author":"Miettinen","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib11","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1161\/01.ATV.17.11.3021","article-title":"Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts","volume":"17","author":"Miettinen","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1050-1738(01)00163-3","article-title":"The effects of altered apolipoprotein A-I structure on plasma HDL concentration","volume":"12","author":"Sorci-Thomas","year":"2002","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib13","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/01.CIR.94.7.1622","article-title":"Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease","volume":"94","author":"Miccoli","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib14","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0022-2275(20)37205-9","article-title":"A\u00a0natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma","volume":"38","author":"Miccoli","year":"1997","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2004.06.070","article-title":"A\u00a0novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease","volume":"44","author":"Hovingh","year":"2004","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.ATV.18.8.1242","article-title":"Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease","volume":"18","author":"Miller","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib17","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1107\/S0907444999008914","article-title":"Crystallization of truncated human apolipoprotein A-I in a novel conformation","volume":"55","author":"Borhani","year":"1999","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib18","doi-asserted-by":"crossref","first-page":"38570","DOI":"10.1074\/jbc.M111.260422","article-title":"Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization","volume":"286","author":"Mei","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib19","doi-asserted-by":"crossref","first-page":"21292","DOI":"10.1074\/jbc.M100463200","article-title":"Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia","volume":"276","author":"McManus","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib20","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1021\/bi7003203","article-title":"LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN","volume":"46","author":"Koukos","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib21","doi-asserted-by":"crossref","first-page":"14353","DOI":"10.1021\/bi050962o","article-title":"Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency","volume":"44","author":"Chroni","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0076-6879(96)63017-1","article-title":"Two-dimensional nondenaturing electrophoresis of lipoproteins: applications to high-density lipoprotein speciation","volume":"263","author":"Fielding","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0022-2275(20)31582-0","article-title":"A\u00a0cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids","volume":"42","author":"Navab","year":"2001","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.ATV.21.4.481","article-title":"HDL and the inflammatory response induced by LDL-derived oxidized phospholipids","volume":"21","author":"Navab","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib25","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1172\/JCI118359","article-title":"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein","volume":"96","author":"Watson","year":"1995","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI117726","article-title":"Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein","volume":"95","author":"Watson","year":"1995","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.109.199158","article-title":"The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages","volume":"30","author":"de la Llera-Moya","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib28","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/ATVBAHA.109.194548","article-title":"Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent","volume":"29","author":"Larrede","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200418004","article-title":"HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3","volume":"113","author":"Nofer","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/89986","article-title":"High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase","volume":"7","author":"Yuhanna","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib31","doi-asserted-by":"crossref","first-page":"9142","DOI":"10.1074\/jbc.M211394200","article-title":"High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases","volume":"278","author":"Mineo","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-2275(20)42785-3","article-title":"Synthetic low and high fat diets for the study of atherosclerosis in the mouse","volume":"31","author":"Nishina","year":"1990","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0022-2275(20)42043-7","article-title":"Effects of atherogenic diet consumption on lipoproteins in mouse strains C57BL\/6 and C3H","volume":"32","author":"Ishida","year":"1991","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-3-319-09665-0_10","article-title":"Dysfunctional HDL: from structure-function-Relationships to Biomarkers","volume":"224","author":"Riwanto","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2008.08.038","article-title":"Functional LCAT is not required for macrophage cholesterol efflux to human serum","volume":"204","author":"Calabresi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.116.305485","article-title":"HDL particle size is a critical Determinant of ABCA1-mediated macrophage Cellular cholesterol Export","volume":"116","author":"Du","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib37","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1021\/bi901564g","article-title":"Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1","volume":"48","author":"Favari","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2015.08.028_bib38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.bbalip.2011.08.019","article-title":"Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice","volume":"1821","author":"Sorci-Thomas","year":"2012","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015300915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015300915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T17:54:25Z","timestamp":1653069265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015300915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0021915015300915"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.028","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}